I don’t know about being extremely close to revenues. There are still quite a few hurdles to take. The (timely) BLA filing. FDA approval needed. Also marketing and sales have to be set up. Once the BLA has been filed the question about costs and financing of marketing and sales becomes our next “problem”. Currently everybody is to occupied with getting to the BLA filing and is paying little attention to the marketing and sales “issues”.
Without any partnerships or outlicensing that is going to be a real challenge. We’re not there yet (revenues).